EmployblEmploybl logo
employbl
Obsidian Therapeutics logo

Obsidian Therapeutics Funding & Investors

Obsidian Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops adoptive cell therapies for the treatment of patient with cancer diseases. Obsidian Therapeutics serves customers in the State of Massachusetts.

obsidiantx.com

Total Amount Raised: $325,000,000

Obsidian Therapeutics Funding Rounds

  • Series C

    $160,500,000

    Series C Investors

    Wellington Management
    Foresite Capital
    RTW Investments
    Novo Holdings
    Janus Henderson
    Woodline Partners
    Atlas Venture
    Paradigm BioCapital Advisors
    Bristol-Myers Squibb
    Samsara BioCapital
    Ra Capital Management
    Blue Owl
    Deep Track Capital
    Surveyor Capital
    Logos Capital
    TCG Crossover Management
    T. Rowe Price

  • Series B

    $115,000,000

    Series B Investors

    Column Group
    Pivotal bioVenture Partners Investment Advisor
    Soleus Capital
    Cowen
    Surveyor Capital
    Samsara BioCapital
    Deep Track Capital
    Logos Capital
    Ra Capital Management
    Atlas Venture
    Bristol-Myers Squibb
    Amgen
    Vertex Ventures HC
    TCG Crossover Management

  • Series A

    $49,500,000

    Series A Investors

    GV
    Takeda Ventures
    Atlas Venture
    Amgen
    ShangPharma
    Alexandria Venture Investments
    Vertex Ventures HC
    Vertex Ventures
    Vertex Pharmaceuticals
Funding info provided by Diffbot.